Companies: 10,795·Total market cap: $144.5T
Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc.

IRWDNASDAQHealthcare● Active
$3.29
$-0.02(-0.60%)
Market Cap$541576770
P/E Ratio
52W High$5.78
52W Low$0.56
Overview

Ironwood Pharmaceuticals, Inc. (IRWD) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · IRWD · as of Jun 8, 2026

Key Statistics

EPS (TTM)$0.64irwd eps ttm · irwd earnings per shareEarnings history
PE Ratio (TTM)5.2×irwd pe ratio ttm · irwd price to earningsPE Ratio deep dive
Revenue (TTM)$361.5Mirwd revenue ttm · irwd annual revenueFull revenue history
Dividend YieldNo Dividenddoes irwd pay dividends · irwd dividend yieldDividend history
Shares Outstanding162.2Mirwd shares outstanding · irwd floatShares outstanding history
Next EarningsAug 6, 2026Est.irwd earnings date · irwd next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$296.2M▼ 15.72% YoY
202320242025
ironwood pharmaceuticals, inc. revenue · irwd revenue 2025
FY 2025Net Income$24.0M▲ +2629.20% YoY
202320242025
ironwood pharmaceuticals, inc. net income · irwd profit 2025
FY 2025EPS$0.15▲ +2627.27% YoY
202320242025
irwd eps · ironwood pharmaceuticals, inc. earnings per share 2025
TTM:Revenue: $361.5MNet Income: $102.2MEPS: $0.64View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold30 analystsis irwd a buy · irwd analyst rating
Strong Buy
0
Buy
11
Hold
16
Sell
3
Strong Sell
0
12-Month Price Target
$3.70Low
$3.29Current
$4.80Avg Target45.90% upside
$5.70High
irwd price target · irwd 12 month forecast

Total: 30 · Buy rate: 36.7%

The IRWD analyst consensus is Hold, based on ratings from 30 Wall Street analysts over the past 3 months. The average 12-month price target is $4.80, representing +45.90% upside from the current price of $3.29.

Stock Performance

Full History
1D-0.60%
1W-0.30%
1M-22.04%
3M-6.00%
YTD-2.37%
1Y+461.34%
5Y-71.29%

About Ironwood Pharmaceuticals, Inc.

CEOThomas A. McCourt
IPO DateFeb 3, 2010
Employees253
CountryUS

Ironwood Pharmaceuticals, Inc. operates as a healthcare enterprise primarily dedicated to discovering, developing, and commercializing therapeutic solutions for gastrointestinal (GI) conditions. Its f…

what is ironwood pharmaceuticals, inc. · irwd stock overview · ironwood pharmaceuticals, inc. company profile · who is ironwood pharmaceuticals, inc. ceo · irwd NASDAQ · ironwood pharmaceuticals, inc. headquarters · ironwood pharmaceuticals, inc. business segments

About Stock Overview & Key Data

Ironwood Pharmaceuticals, Inc. (IRWD) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Feb 3, 2010. As of the latest trading session, IRWD stock price is $3.29, with a market capitalization of $541.6M. The stock has returned +461.34% over the past 12 months and -2.37% year-to-date.

According to 30 Wall Street analysts, the consensus rating for Ironwood Pharmaceuticals, Inc. stock is Hold, with an average 12-month price target of $4.80. In fiscal year 2025, Ironwood Pharmaceuticals, Inc. reported revenue of $296.2M and net income of $24.0M. For detailed data — including Ironwood Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Ironwood Pharmaceuticals, Inc. (IRWD) stock price is $3.29. The stock is traded on NASDAQ under the ticker symbol IRWD. The 52-week range is $0.56 – $5.78.

IRWD stock priceIRWD quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice